We found 10 episodes of Radio Advisory with the tag “clinical innovation and affordability”.
-
191: What CEOs need to know in 2024 (Part 1)
January 16th, 2024 | 32 mins 33 secs
clinical innovation and affordability, clinical workforce, industry consolidation, provider strategy and financial outlook
In this episode, host Rachel Woods invites Advisory Board experts Natalie Trebes, Prianca Pai, and Sharon Yuen to discuss the industry changes that healthcare leaders need to know now and prepare for in 2024.
-
189: A preview of Advisory Board's 2024 research
December 12th, 2023 | 24 mins 57 secs
clinical innovation and affordability, clinical workforce, physician landscape, provider strategy and financial outlook, service lines, tech and ai, value-based care
In this episode, host Rachel Woods invites 11 Advisory Board experts to discuss what's on their radar – and what should be on yours, too – as we approach 2024.
-
186: The new era of drugs is now
November 21st, 2023 | 26 mins 4 secs
clinical innovation and affordability
In this episode, host Rachel Woods invites Advisory Board pharmacy experts Rachel Peroutky and Chloe Bakst to discuss how stakeholders should be preparing themselves for the new era of pharmaceutical drugs.
-
177: Advancing equity in a world of innovation for some, costs for all: Live from the 2023 Clinical Innovation Summit
September 19th, 2023 | 52 mins 32 secs
clinical innovation and affordability, external guests
In this episode, live from Advisory Board's 2023 Clinical Innovation Summit, host Rachel (Rae) Woods invites Maia Laing, SVP of Health Equity for UnitedHealth Group, and Michael Mejia, Advisory Board's director of life sciences research, to discuss how leaders can think about deploying, designing, and financing new clinical innovations in an equitable way.
-
174: Quest's vision for genomics at scale
August 8th, 2023 | 34 mins 26 secs
clinical innovation and affordability, external guests
In this episode, guest host and Advisory Board executive partner Devin Airey invites Mark Gardner, the SVP of Genomic Medicine and Oncology at Quest Diagnostics, and Dan Edelstein, President and CEO of Haystack Oncology, to discuss their vision for genomics and how they are thinking about addressing stakeholder concerns.
-
168: Having the tech isn't enough: the future of clinical decision making
June 27th, 2023 | 30 mins 51 secs
clinical innovation and affordability, external guests, tech and ai
Guest host and Advisory Board life sciences expert Solomon Banjo invites his colleague Amanda Okaka and Optum’s Senior Vice President of Clinical Innovation Dr. Kevin Larson to discuss their predictions for the future of clinical decision making and how organizations can integrate new innovations into clinician workflow.
-
167: How nervous should we be about high-cost drugs?
June 20th, 2023 | 24 mins 5 secs
clinical innovation and affordability
In this episode, host Rachel Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to discuss how industry stakeholders are thinking about the rise of high-cost drugs.
-
159: Ozempic, Wegovy, and our questions on weight management drugs
April 18th, 2023 | 41 mins 5 secs
clinical innovation and affordability
Host Rachel Woods talks with researchers Kara Marlatt, Gaby Marmolejos, and Chloe Bakst about the questions healthcare leaders have about the growing demand and accessibility of new weight management drugs and what this could mean for the industry.
-
146: Part 2: What CEOs need to know in 2023
January 17th, 2023 | 35 mins 5 secs
clinical innovation and affordability, clinical workforce, industry consolidation, provider strategy and financial outlook
Host Rachel Woods joins Advisory Board executive strategy experts Natalie Trebes and Aaron Mauck to talk about what leaders need to know today to shape the future of healthcare beyond 2023.
-
145: Part 1: What CEOs need to know in 2023
January 10th, 2023 | 28 mins 16 secs
clinical innovation and affordability, clinical workforce, industry consolidation, provider strategy and financial outlook
Host Rachel Woods joins Advisory Board executive strategy experts Natalie Trebes and Aaron Mauck to talk about the top forces impacting healthcare in 2023 and the opportunities where leaders can have a hand in shaping the industry's future.